Iron metabolism is involved in many biological processes in the brain. Alterations in iron homeostasis have been associated with several neurodegenerative disorders. Instead of stroke and ischemic heart disease, dementia has become the second leading cause of mortality among the type 2 diabetes mellitus (T2DM) population. Therefore, we attempted to investigate the role of ferroptosis in diabetes-associated cognitive dysfunction (DACD).
Results:
We evaluated ferroptosis hallmarks in the hippocampus of T2DM (high-fat diet/streptozotocin, HFD/STZ) mice, primary hippocampal neurons, as well as in the blood of patients. The results of Gene Set Enrichment Analysis showed significantly differentially expressed genes related to ferroptosis-related pathways between normal control (db/m) and leptin receptor-deficient (db/db) mice. Here, ferroptosis, mitochondrial dysfunction and cognitive impairment were revealed, and caveolin-1 (cav-1) was significantly downregulated in the hippocampus of T2DM (HFD/STZ) mice. In addition, ferrostatin-1 and cav-1 restoration neutralized ferroptosis-related symbolic changes, mitochondrial dysfunction, and improved cognitive dysfunction. Notably, the plasma levels of Fe2+ and 4-hydroxynonenal (4-HNE) in T2DM patients showed a tendency to increase compared with those in nondiabetic subjects, and the Fe2+ level was negatively correlated with the cognitive ability in T2DM subjects.
Innovation:
For the first time, this study suggested that ferroptosis promoted the progression of DACD induced by T2DM both in vivo and in vitro, and supported the clinical evidence for the correlation between ferroptosis and T2DM-related DACD, which provided new insights into the potential antioxidant effects of ferroptosis inhibitors and cav-1 on DACD.
Conclusions:
The overexpression of cav-1 may attenuate DACD by modulating neuronal ferroptosis-mediated mitochondrial homeostasis. We put cav-1 on the spotlight as a promising candidate to prevent DACD. Antioxid. Redox Signal. 37, 867–886.
Graphical abstract
Get full access to this article
View all access options for this article.
References
1.
AbdulY, LiW, WardR, AbdelsaidM, HafezS, DongG, JamilS, WolfV, JohnsonM, FaganS, and ErgulA. Deferoxamine treatment prevents post-stroke vasoregression and neurovascular unit remodeling leading to improved functional outcomes in type 2 male diabetic rats: role of endothelial ferroptosis. Transl Stroke Res, 12: 615–630, 2021.
2.
Area-GomezE, Guardia-LaguartaC, SchonE, and PrzedborskiS. Mitochondria, OxPhos, and neurodegeneration: cells are not just running out of gas. J Clin Invest, 129: 34–45, 2019.
3.
BaoWD, PangP, ZhouXT, HuF, and ZhuLQ. Loss of ferroportin induces memory impairment by promoting ferroptosis in Alzheimer's disease. Cell Death Differ, 28(Suppl 1): 1548–1562, 2021.
4.
BaoW-D, ZhouX-T, ZhouL-T, WangF, YinX, LuY, ZhuL-Q, and LiuD. Targeting miR-124/Ferroportin signaling ameliorated neuronal cell death through inhibiting apoptosis and ferroptosis in aged intracerebral hemorrhage murine model. Aging Cell, 19: e13235, 2020.
5.
BersukerK, HendricksJ, LiZ, MagtanongL, FordB, TangP, RobertsM, TongB, MaimoneT, ZoncuR, BassikM, NomuraD, DixonS, and OlzmannJ. The CoQ oxidoreductase FSP1 acts parallel to GPX4 to inhibit ferroptosis. Nature, 575: 688–692, 2019.
6.
BiesselsGJ and WhitmerRA. Cognitive dysfunction in diabetes: how to implement emerging guidelines. Diabetologia, 63: 3–9, 2020.
7.
BlascoG, PuigJ, Daunis-I-EstadellaJ, MolinaX, XifraG, Fernández-ArandaF, PedrazaS, RicartW, Portero-OtínM, and Fernández-RealJ. Brain iron overload, insulin resistance, and cognitive performance in obese subjects: a preliminary MRI case-control study. Diabetes Care, 37: 3076–3083, 2014.
8.
BondsJA, ShettiA, BheriA, ChenZ, DisoukyA, TaiL, MaoM, HeadBP, BoniniMG, HausJM, MinshallRD, and LazarovO. Depletion of caveolin-1 in type 2 diabetes model induces Alzheimer's disease pathology precursors. J Neurosci, 39: 8576–8583, 2019.
CalabreseV, CopaniA, TestaD, RavagnaA, SpadaroF, TendiE, NicolettiVG, and Giuffrida StellaAM. Nitric oxide synthase induction in astroglial cell cultures: effect on heat shock protein 70 synthesis and oxidant/antioxidant balance. J Neurosci Res, 60: 613–622, 2000.
11.
CalabreseV, CorneliusC, Dinkova-KostovaAT, CalabreseEJ, and MattsonMP. Cellular stress responses, the hormesis paradigm, and vitagenes: novel targets for therapeutic intervention in neurodegenerative disorders. Antioxid Redox Signal, 13: 1763, 2010.
12.
CarvalhoC, SantosM, OliveiraC, and MoreiraP. Alzheimer's disease and type 2 diabetes-related alterations in brain mitochondria, autophagy and synaptic markers. Biochim Biophys Acta, 1852: 1665–1675, 2015.
13.
CobleyJ, FiorelloM, and BaileyD. 13 Reasons why the brain is susceptible to oxidative stress. Redox Biol, 15: 490–503, 2018.
14.
CohenAW, HnaskoR, SchubertW, and LisantiMP. Role of caveolae and caveolins in health and disease. Physiol Rev, 84: 1341–1379, 2004.
15.
ConradM and Friedmann AngeliJ. Glutathione peroxidase 4 (Gpx4) and ferroptosis: what's so special about it?. Mol Cell Oncol, 2: e995047, 2015.
16.
DengG, LiY, MaS, GaoZ, ZengT, ChenL, YeH, YangM, ShiH, YaoX, ZengZ, ChenY, SongY, LiuB, and GaoL. Caveolin-1 dictates ferroptosis in the execution of acute immune-mediated hepatic damage by attenuating nitrogen stress. Free Radic Biol Med, 148: 151–161, 2020.
17.
DixonJS, LembergMK, LamprechtRM, SkoutaR, and ZaitsevME. Ferroptosis: an iron-dependent form of nonapoptotic cell death. Cell, 149: 1060–1072, 2012.
DrakesmithH, NemethE, and GanzT. Ironing out ferroportin. Cell Metab, 22: 777–787, 2015.
20.
Fernández-RealJ, MorenoJ, López-BermejoA, ChicoB, VendrellJ, and RicartW. Circulating soluble transferrin receptor according to glucose tolerance status and insulin sensitivity. Diabetes Care, 30: 604–608, 2007.
21.
FriedewaldWT. Effects of intensive glucose lowering in type 2 diabetes. J Vasc Surg, 358: 2545, 2008.
22.
GaoS, ChenY, SangF, YangY, XiaJ, LiX, ZhangJ, ChenK, and ZhangZ. White matter microstructural change contributes to worse cognitive function in patients with type 2 diabetes. Diabetes, 68: 2085–2094, 2019.
23.
GrønborgM, PavlosN, BrunkI, ChuaJ, Münster-WandowskiA, RiedelD, Ahnert-HilgerG, UrlaubH, and JahnR. Quantitative comparison of glutamatergic and GABAergic synaptic vesicles unveils selectivity for few proteins including MAL2, a novel synaptic vesicle protein. J Neurosci, 30: 2–12, 2010.
24.
HanK, JinX, GuoX, CaoG, TianS, SongY, ZuoY, YuP, GaoG, and ChangY-Z. Nrf2 knockout altered brain iron deposition and mitigated age-related motor dysfunction in aging mice. Free Radic Biol Med, 162: 592–602, 2021.
25.
HaoL, MiJ, SongL, GuoY, LiY, YinY, and ZhangC. SLC40A1 mediates ferroptosis and cognitive dysfunction in type 1 diabetes. Neuroscience, 463: 216–226, 2021.
26.
This reference has been deleted.
27.
JinawongK, ApaijaiN, WongsuchaiS, PratchayasakulW, ChattipakornN, and ChattipakornS. Necrostatin-1 mitigates cognitive dysfunction in prediabetic rats with no alteration in insulin sensitivity. Diabetes, 69: 1411–1423, 2020.
28.
This reference has been deleted.
29.
KalininaEV, ChernovNN, and NovichkovaM. Role of glutathione, glutathione transferase, and glutaredoxin in regulation of redox-dependent processes. Biochemistry (Moscow), 79: 1562–1583, 2015.
30.
This reference has been deleted.
31.
LiJ, ZhangQ, ZhangN, and GuoL. Increased brain iron detection by voxel-based quantitative susceptibility mapping in type 2 diabetes mellitus patients with an executive function decline. Front Neurosci, 14: 606182, 2020.
32.
LiK, JiangJ, ShiZ, ZhanL, PengL, SunW, TangY, ZuoX, and XuE. Neuroprotective effects of rhodiola sacra on transient global cerebral ischemia through activating AMPK/Nrf2 pathway in rats. Antioxid Redox Signal, 36: 567–591, 2022.
33.
LiuJ, HuX, XueY, LiuC, LiuD, ShangY, ShiY, ChengL, ZhangJ, ChenA, and WangJ. Targeting hepcidin improves cognitive impairment and reduces iron deposition in a diabetic rat model. Am J Transl Res, 12: 4830–4839, 2020.
LuoQ, XianP, WangT, WuS, SunT, WangW, WangB, YangH, YangY, WangH, LiuW, and LongQ. Antioxidant activity of mesenchymal stem cell-derived extracellular vesicles restores hippocampal neurons following seizure damage. Theranostics, 11: 5986–6005, 2021.
36.
This reference has been deleted.
37.
MaH, JiangT, TangW, MaZ, PuK, XuF, ChangH, ZhaoG, GaoW, LiY, and WangQ. Transplantation of platelet-derived mitochondria alleviates cognitive impairment and mitochondrial dysfunction in db/db mice. Clin Sci (Lond), 134: 2161–2175, 2020.
38.
MaL, AzadMG, DharmasivamM, RichardsonV, and RichardsonDR. Parkinson's disease: alterations in iron and redox biology as a key to unlock therapeutic strategies. Redox Biol, 41: 101896, 2021.
MarroS, ChiabrandoD, MessanaE, StolteJ, TurcoE, TolosanoE, and MuckenthalerMU. Heme controls ferroportin1 (FPN1) transcription involving Bach1, Nrf2 and a MARE/ARE sequence motif at position -7007 of the FPN1 promoter. Haematologica, 95: 1261–1268, 2010.
41.
MasaldanS, BushA, DevosD, RollandA, and MoreauC. Striking while the iron is hot: iron metabolism and ferroptosis in neurodegeneration. Free Radic Biol Med, 133: 221–233, 2019.
42.
MiottoG, RossettoM, PaoloM, OrianL, and CozzaG. Insight into the mechanism of ferroptosis inhibition by ferrostatin-1. Redox Biol, 28: 101328, 2019.
43.
NaguibY. A fluorometric method for measurement of peroxyl radical scavenging activities of lipophilic antioxidants. Anal Biochem, 265: 290–298, 1998.
44.
NasriH, ShirzadH, BaradaranA, and Rafieian-KopaeiM. Antioxidant plants and diabetes mellitus. J Res Med Sci, 20: 491–502, 2015.
45.
This reference has been deleted.
46.
Pearson-StuttardJ, BennettJ, ChengYJ, VamosEP, CrossAJ, EzzatiM, and GreggEW. Trends in predominant causes of death in individuals with and without diabetes in England from 2001 to 2018: an epidemiological analysis of linked primary care records. Lancet Diabetes Endocrinol, 9: 165–173, 2021.
47.
PerluigiM, Di DomenicoF, GiorgiA, SchininàM, CocciaR, CiniC, BelliaF, CambriaM, CorneliusC, ButterfieldD, and CalabreseV. Redox proteomics in aging rat brain: involvement of mitochondrial reduced glutathione status and mitochondrial protein oxidation in the aging process. J Neurosci Res, 88: 3498–3507, 2010.
48.
PuK. Semiconducting polycomplex nanoparticles for photothermal ferrotherapy of cancer. Angew Chem Int Ed Engl, 59: 10633–10638, 2020.
49.
QiG, MiY, ShiX, GuH, BrintonR, and YinF. ApoE4 impairs neuron-astrocyte coupling of fatty acid metabolism. Cell Rep, 34: 108572, 2021.
50.
This reference has been deleted.
51.
ShirotoT, RomeroN, SugiyamaT, SartorettoJL, KalwaH, YanZ, ShimokawaH, and MichelT. Caveolin-1 is a critical determinant of autophagy, metabolic switching, and oxidative stress in vascular endothelium. PLoS One, 9: e87871, 2014.
52.
SlotenT, SedaghatS, CarnethonMR, LaunerLJ, and StehouwerC. Cerebral microvascular complications of type 2 diabetes: stroke, cognitive dysfunction, and depression. Lancet Diabetes Endocrinol, 8: 325–336, 2020.
53.
SmithMA, HarrisP, SayreLM, and PerryG. Iron accumulation in Alzheimer disease is a source of redox-generated free radicals. Proc Natl Acad Sci U S A, 94: 9866–9868, 1997.
54.
SwaminathanS, FonsecaVA, AlamMG, and ShahSV. The role of iron in diabetes and its complications. Diabetes Care, 30: 1926, 2007.
55.
This reference has been deleted.
56.
TaliCY, GersteinHC, MillerME, LaunerLJ, WilliamsonJD, HorowitzKR, Fa RamarzIB, and LazarRM. The relationship between the score on a simple measure of cognitive function & incident CVD in people with diabetes: a post-hoc epidemiological analysis from the ACCORD-MIND study. J Clin Endocrinol Metab, 102: 3218–3225, 2017.
57.
TangD, ChenX, KangR, and KroemerG. Ferroptosis: molecular mechanisms and health implications. Cell Res, 31: 107–125, 2021.
58.
TangW, LiY, LiY, and WangQ. Caveolin-1, a novel player in cognitive decline. Neurosci Biobehav Rev, 129: 95–106, 2021.
59.
TangW, ZhangL, and LiZ. Long noncoding RNA LOC100911498 is a novel regulator of neuropathic pain in rats. Brain Behav, 11: e01966, 2021.
60.
WangG, CuiW, ChenS, ShaoZ, LiY, WangW, MaoL, LiJ, and MeiX. Metformin alleviates high glucose-induced ER stress and inflammation by inhibiting the interaction between caveolin1 and AMPKα in rat astrocytes. Biochem Biophys Res Commun, 534: 908–913, 2021.
61.
WangH, AnP, XieE, WuQ, FangX, GaoH, ZhangZ, LiY, WangX, ZhangJ, LiG, YangL, LiuW, MinJ, and WangF. Characterization of ferroptosis in murine models of hemochromatosis. Hepatology, 66: 449–465, 2017.
62.
WangH, LiuC, ZhaoY, and GaoG. Mitochondria regulation in ferroptosis. Eur J Cell Biol, 99: 151058, 2019.
63.
WangH, WangZ, DingY, PiaoM, FengC, ChiG, LuoY, and GeP. Endoplasmic reticulum stress regulates oxygen-glucose deprivation-induced parthanatos in human SH-SY5Y cells via improvement of intracellular ROS. CNS Neurosci Ther, 24: 29–38, 2018.
64.
WangJ, JiangW, XinJ, XueW, ShiC, WenJ, HuangY, and HuC. Caveolin-1 alleviates acetaminophen-induced fat accumulation in non-alcoholic fatty liver disease by enhancing hepatic antioxidant ability via activating AMPK pathway. Front Pharmacol, 12: 717276, 2021.
65.
WangX, FangH, XuG, YangY, XuR, LiuQ, XueX, LiuJ, and WangH. Resveratrol prevents cognitive impairment in type 2 diabetic mice by upregulating Nrf2 expression and transcriptional level. Diabetes Metab Syndr Obes, 13: 1061–1075, 2020.
66.
WangX, SunG, FengT, ZhangJ, HuangX, WangT, XieZ, ChuX, YangJ, WangH, ChangS, GongY, RuanL, ZhangG, YanS, LianW, DuC, YangD, ZhangQ, LinF, LiuJ, ZhangH, GeC, XiaoS, DingJ, and GengM. Sodium oligomannate therapeutically remodels gut microbiota and suppresses gut bacterial amino acids-shaped neuroinflammation to inhibit Alzheimer's disease progression. Cell Res, 29: 787–803, 2019.
67.
WangY, HuangY, XuY, RuanW, WangH, ZhangY, SaavedraJM, ZhangL, HuangZ, and PangT. A dual AMPK/Nrf2 activator reduces brain inflammation after stroke by enhancing microglia M2 polarization. Antioxid Redox Signal, 28: 141–163, 2018.
68.
WardR, ZuccaFA, DuynJH, CrichtonRR, and ZeccaL. The role of iron in brain ageing and neurodegenerative disorders. Lancet Neurol, 13: 1045–1060, 2014.
World Health Organization (WHO). WHO reveals leading causes of death and disability worldwide: 2000–2019. December 9, 2020. https://www.who.int/news/item/09-12-2020-who-reveals-leading-causes-of-death-and-disability-worldwide-2000-2019 accessed February28, 2022.
71.
WuJ, ZhouSL, PiLH, ShiXJ, MaLR, ChenZ, QuML, LiX, NieSD, LiaoDF, PeiJJ, and WangS. High glucose induces formation of tau hyperphosphorylation via Cav-1-mTOR pathway: a potential molecular mechanism for diabetes-induced cognitive dysfunction. Oncotarget, 8: 40843–40856, 2017.
72.
XieY, HouW, SongX, YuY, HuangJ, SunX, KangR, and TangD. Ferroptosis: process and function. Cell Death Differ, 23: 369–379, 2016.
73.
YanH, ZouT, TuoQ, XuS, LiH, BelaidiA, and LeiP. Ferroptosis: mechanisms and links with diseases. Signal Transduct Target Ther, 6: 49, 2021.
74.
YangL, LiX, JiangA, LiX, ChangW, ChenJ, and YeF. Metformin alleviates lead-induced mitochondrial fragmentation via AMPK/Nrf2 activation in SH-SY5Y cells. Redox Biol, 36: 101626, 2020.
75.
YangW, SriRamaratnamR, WelschM, ShimadaK, SkoutaR, ViswanathanV, CheahJ, ClemonsP, ShamjiA, ClishC, BrownL, GirottiA, CornishV, SchreiberS, and StockwellB. Regulation of ferroptotic cancer cell death by GPX4. Cell, 156: 317–331, 2014.
76.
YuH, LiuY, HeT, ZhangY, HeJ, LiM, JiangB, GaoY, ChenC, KeD, LiuJ, HeB, YangX, and WangJ. Platelet biomarkers identifying mild cognitive impairment in type 2 diabetes patients. Aging Cell, 20: e13469, 2021.
77.
YunJ, LeeD, JeongH, KimH, YeS, and ChoC. STAT3 activation in microglia exacerbates hippocampal neuronal apoptosis in diabetic brains. J Cell Physiol, 236: 7058–7070, 2021.
78.
YunJH, ParkSJ, JoA, KangJL, JouI, ParkJS, and ChoiYH. Caveolin-1 is involved in reactive oxygen species-induced SHP-2 activation in astrocytes. Exp Mol Med, 43: 660–668, 2011.
79.
ZeinivandM, NahavandiA, and ZareM. Deferoxamine regulates neuroinflammation and oxidative stress in rats with diabetes-induced cognitive dysfunction. Inflammopharmacology, 28: 575–583, 2019.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
